iPSC Differentiation to Cardiomyocytes | Applied StemCell

We provide top-quality service for the directed differentiation of iPSCs into cardiomyocytes using our efficient induction protocol and reagents. We deliver ready-to-use, functional ventricular and atrial cardiomyocytes that are desirable

in vitro

models for high-content toxicity and drug screening, and cell regeneration research. We deliver receive feasible and physiologically relevant alternatives to embryonic stem cells, primary cells, and animal models.

  • High-quality atrial and ventricular cardiomyocytes
  • Biomarkers:

    • cTNT, alpha-SMA, MLC2A, and MLC2V; video of beating cells

  • We can generate differentiated cardiomyocytes from iPSC derived from healthy or disease patient samples
  • Fast turnaround:

    2 weeks

  • GMP iPSC Differentiation Services Available >> Learn More

Get iPSCs to genetically modify and further differentiate into immune cells? We offer fully customizable

iPSC generation

from human or non-human tissue samples, and our genome editing experts can use

CRISPR or TARGATT™  to genetically alter the iPSCs

to fit your project requirements. If you need to expedite your experimental timeline, ASC also offers off-the-shelf

cardiomyocytes

. Contact us today to find the best solution for your projects.




youtube icon



Beating iPSC-Derived Cardiomyocytes – Video 1| Applied StemCell, Inc.





youtube icon



Beating iPSC-Derived Cardiomyocytes – Video 2 | Applied StemCell, Inc.